ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,882,306 | +15.4% | 91,864 | +11.9% | 0.01% | +16.7% |
| Q2 2023 | $1,631,618 | +139953.0% | 82,114 | +20.6% | 0.01% | +20.0% |
| Q1 2023 | $1,165 | +26.5% | 68,114 | +44.6% | 0.01% | 0.0% |
| Q4 2022 | $921 | -99.9% | 47,114 | +11.9% | 0.01% | +66.7% |
| Q3 2022 | $671,000 | +25.0% | 42,114 | +7.9% | 0.00% | 0.0% |
| Q2 2022 | $537,000 | -13.1% | 39,040 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $618,000 | -26.3% | 39,002 | +1.6% | 0.00% | -25.0% |
| Q4 2021 | $838,000 | +112.7% | 38,402 | +190.9% | 0.00% | +100.0% |
| Q3 2021 | $394,000 | +282.5% | 13,202 | +466.6% | 0.00% | +100.0% |
| Q1 2021 | $103,000 | -18.9% | 2,330 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $127,000 | +28.3% | 2,330 | -50.9% | 0.00% | 0.0% |
| Q2 2020 | $99,000 | +50.0% | 4,743 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $66,000 | -53.8% | 4,743 | -24.5% | 0.00% | -50.0% |
| Q4 2019 | $143,000 | +93.2% | 6,281 | -1.3% | 0.00% | +100.0% |
| Q3 2019 | $74,000 | -26.0% | 6,361 | -3.8% | 0.00% | 0.0% |
| Q2 2019 | $100,000 | -13.8% | 6,609 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $116,000 | +27.5% | 6,609 | +8.2% | 0.00% | 0.0% |
| Q4 2018 | $91,000 | -39.3% | 6,109 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $150,000 | – | 6,109 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |